Vincent M. Rotello, Ph.D., named new Editor-in-Chief of Bioconjugate Chemistry
WASHINGTON, Sept. 26, 2013 — The American Chemical Society (ACS) announces that Vincent M. Rotello, Ph.D., will assume the role of Editor-in-Chief of Bioconjugate Chemistry. Rotello is currently the Charles A. Goessmann Professor of Chemistry, with an appointment in the Program in Molecular and Cellular Biology, at the University of Massachusetts Amherst.
Rotello will succeed founding Editor-in-Chief Claude F. Meares, Ph.D., who has served in this position since 1990 and will retire from the journal at the end of the year. Meares is Emeriti Faculty, Professor of Chemistry, at the University of California, Davis.
Rotello earned his B. Sc. (Honors) from the Illinois Institute of Technology in 1985 and his Ph.D. in the area of natural products synthesis from Yale University in 1990. He then moved to the Massachusetts Institute of Technology as a National Science Foundation Postdoctoral Fellow, researching host-guest chemistry in the laboratory of Professor Julius Rebek, Jr. “Bioconjugate Chemistry is the one journal poised exactly at the interface of the biological and synthetic worlds, positioning the journal to contribute to advances in fields including drug delivery, bionanotechnology and synthetic biology,” said Rotello.
Rotello is a Fellow of the American Association for the Advancement of Science and a Fellow of the Royal Society of Chemistry (U.K.). He has received numerous awards and honors for his research, including the John Burlew Award in Research from the ACS. Rotello has published over 380 book chapters, articles and reviews including articles in Bioconjugate Chemistry and other ACS journals including ACS Applied Materials and Interfaces, ACS Macro Letters, ACS Nano, Biomacromolecules, Journal of the American Chemical Society, Langmuir, Macromolecules, Nano Letters and Organic Letters.
“We’re delighted that Vincent Rotello, who has staunchly supported the ACS by authoring in and reviewing for many ACS journals, assumes the leadership of Bioconjugate Chemistry from founding Editor Claude F. Meares,” said Susan King, Senior Vice President of the Journals Publishing Group at ACS. “I would also like to offer my sincerest thanks to Dr. Meares who, during his tenure, shaped a unique publication focused on all aspects of conjugation chemistry, making Bioconjugate Chemistry a leader in its field.”
“Vince Rotello has an outstanding reputation in the biological applications of nanoparticles, and I look forward to his leading Bioconjugate Chemistry in new directions,” said Meares.
Bioconjugate Chemistry began publication in January 1990. The journal publishes research on all aspects of the joining of different molecular functions by chemical or biological means. This includes, among other topics, the conjugation of antibodies, nucleic acids, lipids, carbohydrates or other biologically active molecules and their analogs with any molecular groups that add useful properties. Bioconjugate Chemistry received an Impact Factor of 4.580 with 13,900 total citations in the 2013 release of the Journal Citation Reports® from Thomson Reuters. Learn more about the journal at http://pubs.acs.org/bc.
To automatically receive news releases from the American Chemical Society, contact firstname.lastname@example.org.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 163,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.